Valuation : Bioneer Corporation

Market Cap 268B 199M 171M 161M 147M 275M 18.8B 276M 1.91B 739M 9.65B 748M 731M 31.08B P/E 2024
-23.6x
P/E 2025 -117x
Enterprise Value 282B 209M 180M 170M 155M 290M 19.78B 291M 2B 778M 10.15B 786M 769M 32.69B EV / Sales 2024
1.59x
EV / Sales 2025 1.04x
Free-Float
82.04%
Yield 2024 *
-
Yield 2025 -
1 day+1.46%
1 week+25.03%
Current month+18.20%
1 month+49.71%
3 months+28.75%
6 months-13.56%
Current year-18.51%
1 week 8,480
Extreme 8480
11,300
1 month 6,680
Extreme 6680
11,300
Current year 5,470
Extreme 5470
14,210
1 year 5,470
Extreme 5470
15,640
3 years 5,470
Extreme 5470
43,850
5 years 5,470
Extreme 5470
89,100
10 years 4,355
Extreme 4355
98,800
Manager TitleAgeSince
Chief Executive Officer 64 31/07/1992
Corporate Officer/Principal 62 27/03/2024
Corporate Officer/Principal 51 30/03/2025
Director TitleAgeSince
Director/Board Member 64 17/02/2011
Director/Board Member 62 30/04/1997
Director/Board Member 63 31/01/2000
Date Insider Type Main position Quantity % Market Cap. Importance
12/06/25 Exercice

Director

2,625 0.0102%
03/03/25 Buy

Chief Executive Officer

3,000 0.0116%
22/01/25 Buy 1,579 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%+25.03%-29.03%-74.96% 199M
-1.79%-2.27%+43.23%+88.96% 67.98B
-2.06%-0.18%+39.67%+86.44% 64.94B
-0.31%+6.54%-12.96%+378.92% 27.58B
+0.86%+1.65%-7.74%-14.95% 26.06B
-3.00%-2.90%+33.13%+12.54% 25.74B
-1.46%+0.42%+23.61%-18.61% 20.09B
-2.96%-15.21%+216.20%+368.10% 17.16B
-1.49%-4.88%-6.60%+531.89% 14.92B
-0.20%+8.37%+55.78%+164.98% 14.62B
Average -1.10%+2.05%+35.53%+152.33% 27.93B
Weighted average by Cap. -1.52%+0.19%+38.33%+137.20%

Financials

2024 2025
Net sales 294B 218M 188M 177M 161M 302M 20.61B 303M 2.09B 810M 10.57B 820M 802M 34.07B 330B 245M 211M 198M 181M 339M 23.14B 340M 2.35B 910M 11.87B 920M 900M 38.25B
Net income -20.58B -15.28M -13.15M -12.37M -11.3M -21.15M -1.44B -21.2M -146M -56.74M -740M -57.4M -56.14M -2.39B -2.81B -2.09M -1.8M -1.69M -1.54M -2.89M -197M -2.9M -19.98M -7.75M -101M -7.84M -7.67M -326M
Net Debt -20.54B -15.25M -13.12M -12.35M -11.28M -21.1M -1.44B -21.16M -146M -56.61M -739M -57.27M -56.02M -2.38B 13.9B 10.32M 8.88M 8.36M 7.63M 14.28M 974M 14.32M 98.73M 38.31M 500M 38.75M 37.91M 1.61B
Logo Bioneer Corporation
Bioneer Corp is a Korea-based company engaged in the biotechnology business. The Company mainly operates genetic research, molecular diagnostics, probiotics, and ribonucleic acid interference (RNAi) new drug development businesses. The Company mainly provides services such as gene analysis and synthesis, gene expression, and protein expression and purification. The Company’s products include body fat-reducing lactic acid bacteria in probiotics field, and basic materials, reagents, kits, gene extraction, amplification, quantitative analysis equipment, molecular diagnosis equipment for genetic research and molecular diagnosis used in molecular diagnosis field. The Company also provides laboratory equipment, single products, and laboratory consumables used in biotech research.
Employees
392
Date Price Change Volume
04/09/26 ₩10,390.00 +1.46% 903,391
03/09/26 ₩10,240.00 +2.71% 660,754
02/09/26 ₩9,970.00 -9.36% 1,213,732
01/09/26 ₩11,000.00 +25.14% 5,502,757
31/08/26 ₩8,790.00 +5.78% 650,714
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A064550 Stock